Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4s)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one As a Novel Potent Analgesic.

Huoming Huang,Xueping Li,Peng Xie,Xinwei Li,XueJun Xu,Yuanyuan Qian,Congmin Yuan,Xiangguo Meng,JingRui Chai,Jing Chen,Jing Liu,Wenli Wang,Wei Li,YuJun Wang,Wei Fu,Jinggen Liu

DOI: https://doi.org/10.1021/acs.jmedchem.1c00722

IF: 8.039

2021-01-01

Journal of Medicinal Chemistry

Abstract:Management of moderate to severe pain relies heavily on opioid analgesics such as morphine, oxycodone, and fentanyl in clinics. However, their prolonged use was associated with undesirable side effects. Many new strategies to reduce side effects have been proposed, but not without disadvantages. Using a hot plate model as a phenotypic screening method, our studies identified (3R,4S)-9d with a new scaffold as a potent analgesic with ED50 values of 0.54 mg/kg and 0.021 mg/kg in hot plate and antiwrithing models, respectively. Mechanistic studies showed that it elicited its analgesic effect via the active metabolite (3R,4S)-10a. The mechanism of (3R,4S)-10a-induced activation of the μ opioid receptor (MOR) was proposed by means of molecular dynamics (MD) simulation.